DEA announced proposed permanent rules for prescribing controlled substances via telemedicine and circumstances affecting practitioners ability to prescribe controlled substances without in person medical evaluation of patient outside of COVID 19 public health emergency.
On February 24, 2023, the Drug Enforcement Agency (“DEA”) announced proposed permanent rules around prescribing controlled substances via telemedicine that expand the circumstances.